• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Viruses . SARS-CoV-2 Delta Variant Pathogenesis and Host Response in Syrian Hamsters

tetano

Editor, Senior Moderator
Viruses


. 2021 Sep 5;13(9):1773.
doi: 10.3390/v13091773.
SARS-CoV-2 Delta Variant Pathogenesis and Host Response in Syrian Hamsters


Sreelekshmy Mohandas[SUP] 1 [/SUP], Pragya Dhruv Yadav[SUP] 1 [/SUP], Anita Shete[SUP] 1 [/SUP], Dimpal Nyayanit[SUP] 1 [/SUP], Gajanan Sapkal[SUP] 1 [/SUP], Kavita Lole[SUP] 1 [/SUP], Nivedita Gupta[SUP] 2 [/SUP]



Affiliations

Abstract

B.1.617 is becoming a dominant Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) lineage worldwide with many sublineages, of which B.1.617.2 is designated as a variant of concern. The pathogenicity of B.1.617.2 (Delta) and B.1.617.3 lineage of SARS-CoV-2 was evaluated and compared with that of B.1, an early virus isolate with D614G mutation in a Syrian hamster model. Viral load, antibody response, and lung disease were studied. There was no significant difference in the virus shedding pattern among these variants. High levels of SARS-CoV-2 sub genomic RNA were detected in the respiratory tract of hamsters infected with the Delta variant for 14 days, which warrants further transmission studies. The Delta variant induced lung disease of moderate severity in about 40% of infected animals, which supports the attributed disease severity of the variant. Cross neutralizing antibodies were detected in animals infected with B.1, Delta, and B.1.617.3 variant, but neutralizing capacity was significantly lower with B.1.351 (Beta variant).

Keywords: B.1.617.2; B.1.617.3; Delta variant; SARS-CoV-2; Syrian hamster; pathogenicity.
 
Back
Top Bottom